Alcon TOTAL30 contact lenses

ALCON TOTAL30 is a high-performance monthly replacement contact lens brand featuring advanced Water Gradient technology. The brand is part of Alcon's innovative eye care portfolio, which has a long-standing history in medical aesthetics and ophthalmology. Originally founded in the United States in 1945, Alcon has evolved through various ownerships, most notably being a subsidiary of Novartis for several years before becoming an independent, publicly-traded company in 2019.

Manufacturing of Alcon contact lenses typically occurs across a global network of specialized facilities, primarily located in the United States, Germany, Singapore, and Indonesia. This ensures a broad distribution network for their vision care products. As of 2026, Alcon Inc. remains the ultimate owner, operating as a Swiss-American global medical device company headquartered in Geneva, Switzerland, with major operational hubs in Fort Worth, Texas.